Key Highlights
- ARK Invest acquired 85,485 shares of Palantir totaling approximately $11.15M spread across five ETFs
- The firm divested 44,446 AMD shares valued at roughly $10.52M, trimming semiconductor holdings
- Palantir shares declined approximately 2% Friday following a sharp 7% Thursday decline
- “Big Short” investor Michael Burry flagged Palantir as overvalued, pointing to Anthropic’s competitive threat
- Wedbush analyst Daniel Ives countered Burry’s stance, reaffirming Buy rating with $230 target
Cathie Wood’s investment firm ARK Invest executed significant portfolio adjustments during a two-day trading window on April 10-11, 2026. The firm accumulated Palantir Technologies shares while simultaneously trimming its Advanced Micro Devices position, based on ARK’s public fund transaction records.
The investment manager acquired a total of 85,485 Palantir shares valued at roughly $11.15 million. This purchase was distributed among five different ARK exchange-traded funds: the flagship ARKK fund received 46,455 shares, ARKQ obtained 15,127 shares, ARKW added 11,865 shares, ARKF purchased 5,973 shares, and ARKX secured 6,065 shares.
Palantir Technologies Inc., PLTR
Concurrently, ARK liquidated 44,446 shares of Advanced Micro Devices, representing approximately $10.52 million in value. These divested shares came from identical positions across the same five fund vehicles.
This strategic rebalancing indicates ARK is pivoting capital away from semiconductor manufacturing exposure toward artificial intelligence software infrastructure.
Market Headwinds Hit Palantir
Palantir’s stock experienced significant volatility during the week preceding ARK’s purchase decision. Shares declined about 2% Friday after suffering a steep 7% loss Thursday.
The downturn intensified following commentary from Michael Burry, the legendary investor famous for predicting the 2008 financial crisis. Burry warned via social media platform X that Palantir’s current market valuation reflects “bubble” characteristics.
Burry’s thesis centered on competitive pressure from Anthropic, suggesting the AI startup’s recently launched “Mythos” model and accelerating revenue growth threaten Palantir’s market share. Wood interpreted the price weakness as an attractive entry point.
ARK simultaneously offloaded 75,389 shares of Strata Critical Medical valued at $305,325, extending a weeklong pattern of reducing exposure to that holding.
Wall Street Remains Split
Burry’s bearish perspective hasn’t achieved universal acceptance among market analysts. Wedbush Securities analyst Daniel Ives characterized Burry’s analysis as a “fictional narrative” disconnected from operational reality.
Ives maintained his Buy recommendation on Palantir alongside a $230 price objective. He highlighted the company’s remarkable 137% year-over-year expansion in U.S. Commercial segment revenue as confirmation that Palantir’s market positioning remains robust.
Benchmark analyst Yi Fu Lee takes a more measured stance. Lee contends that Palantir’s elevated valuation multiples require flawless operational execution to support current share prices.
The broader analyst community consensus rates Palantir as a Moderate Buy. This rating reflects 14 Buy recommendations, 5 Hold ratings, and 2 Sell opinions.
Following recent market turbulence, the mean analyst price target stands at $194.61, implying potential upside of approximately 52% from Friday’s market close.
Advanced Micro Devices shares climbed 3.55% during the same session when ARK executed its sale.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
